Crossmark

Glucagon-like peptide-1 (GLP-1) receptor agonists and cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of double-blind, randomized, placebo-controlled clinical trials

Crossref DOI link: https://doi.org/10.1186/s12902-022-01036-0

Published Online: 2022-05-12

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Qin, Jing

Song, Li
License Information

Text and Data Mining valid from 2022-05-12

Version of Record valid from 2022-05-12
More Information

Article History

Received: 19 September 2019

Accepted: 27 February 2020

First Online: 12 May 2022

Declarations

:

: Not applicable.

: Not applicable.

: All authors declare that there are no conflict of interests or special relationships with industry in this meta-analysis.

Document is current

Any future updates will be listed below